Arthi Chakravarthy holds the role of Chief Legal Officer at Enovix Corp (ENVX). Chakravarthy has reported 41 insider filings with the SEC since 2024. The most recent filing was in August 2026.
Every role Arthi Chakravarthy has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Updated Aug 30, 2026
Arthi Chakravarthy is Chief Legal Officer of Enovix Corp (ENVX). 41 SEC Form 4 filings on record going back to 2024, most recently on 26 August 2026. Lifetime open-market sales: $455K.
Every recent SEC Form 4 transaction Arthi Chakravarthy has reported, most recent first.
InsiderAlpha's records for Arthi Chakravarthy go back to 2024: 41 primary Form 4 filings, an average of 13.7 per year. 1 recorded transaction carries a Rule 10b5-1 flag, meaning it was pre-scheduled under a written trading plan rather than discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Arthi Chakravarthy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Arthi Chakravarthy is a corporate insider, tracked as Chief Legal Officer of Enovix Corp (ENVX). InsiderAlpha holds 41 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
8 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases and 1 open-market sale ($455K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
2.2K shares @ $3.95$9K